Diffuse Large B Cell Lymphoma  >>  conatumumab (AMG 655)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
conatumumab (AMG 655) / Amgen
NCT00791011: Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

Completed
1b
33
US
AMG 655, Vorinostat, SAHA, Bortezomib, Velcade
Amgen
Hodgkin's Lymphoma, Low Grade Lymphoma, Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large Cell Lymphoma
07/10
08/11

Download Options